HCPCS Level II · Drugs administered other than oral method
J3371Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg
Terminated 06/30/2025
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J3371
J3371 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg.
It was added to HCPCS effective 01/01/2023, and its current record took effect 07/01/2025.
It was terminated on 06/30/2025 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Inj, vancomycin hcl (mylan)
- Date added
- 01/01/2023
- Action effective
- 07/01/2025
- Termination date
- 06/30/2025
- BETOS
- O1E
Related J33xx codes
- J3300Injection, triamcinolone acetonide (triesence), preservative free, 1 mg
- J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg
- J3302Injection, triamcinolone diacetate, per 5 mg
- J3303Injection, triamcinolone hexacetonide, per 5 mg
- J3304Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
- J3315Injection, triptorelin pamoate, 3.75 mg
- J3316Injection, triptorelin, extended-release, 3.75 mg
- J3350Injection, urea, up to 40 gm
- J3357Ustekinumab, for subcutaneous injection, 1 mg
- J3358Ustekinumab, for intravenous injection, 1 mg
- J3360Injection, diazepam, up to 5 mg
- J3373Injection, vancomycin hydrochloride, 10 mg
Common questions about J3371
Is HCPCS J3371 still valid?
- No. J3371 was terminated on 06/30/2025.
Does Medicare cover J3371?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.